Genmab A/S (GMAB)
31.48
-1.04
(-3.20%)
USD |
NASDAQ |
Dec 30, 16:00
31.35
-0.13
(-0.41%)
After-Hours: 20:00
Genmab Price: 31.48 for Dec. 30, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merus NV | 90.00 |
| AbbVie, Inc. | 229.79 |
| Johnson & Johnson | 206.94 |
| Novo Nordisk A/S | 51.16 |
| Krystal Biotech, Inc. | 248.05 |
Price Related Metrics
| PE Ratio | 13.37 |
| PS Ratio | 5.511 |
| PEG Ratio | 0.1055 |
| Price to Book Value | 3.367 |
| Price to Free Cash Flow | 16.28 |
| Earnings Yield | 7.48% |
| Market Cap | 19.36B |
| PEGY Ratio | 0.1055 |
| Operating PE Ratio | 14.96 |
| Normalized PE Ratio | 13.30 |